Should separate endpoint trials be required for all lipid-lowering drugs acting by the same mechanism?

MeSH terms

• Animals
• Arteriosclerosis / blood
• Arteriosclerosis / diagnostic imaging
• Arteriosclerosis / prevention & control
• Clinical Trials as Topic / methods*
• Drug Evaluation / methods*
• Female
• Guinea Pigs
• Humans
• Hyperlipidemias / blood
• Hyperlipidemias / drug therapy*
• Hypolipidemic Agents / therapeutic use*
• Lipids / blood*
• Male
• Radiography
• Safety
• Treatment Outcome